Biotechnology Eye Drug Eylea Price Manipulation: Regeneron Faces US Justice Department Allegations Over Medicare Pricing Of Its Best-Selling Eye Drug – Regeneron Pharmaceuticals (NASDAQ:REGN) Read more
Biotechnology Vertex’s Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept’s Potential Impact – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Eurozone S&P 500 Down 1%; Delta Air Lines Posts Upbeat Earnings – Adial Pharmaceuticals (NASDAQ:ADIL), Ascent Solar Technologies (NASDAQ:ASTI) Read more
Biotechnology Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies – Eli Lilly and Co (NYSE:LLY), Amphastar Pharma (NASDAQ:AMPH) Read more
Eurozone Crude Oil Edges Higher; Marin Software Shares Jump – Adial Pharmaceuticals (NASDAQ:ADIL), Ascent Solar Technologies (NASDAQ:ASTI) Read more
Biotechnology EXCLUSIVE: Adial Pharmaceuticals’ Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance – Adial Pharmaceuticals (NASDAQ:ADIL) Read more
Eurozone Dow Falls Over 1%; US Inflation Rate Accelerates In March – Adial Pharmaceuticals (NASDAQ:ADIL), Ascent Solar Technologies (NASDAQ:ASTI) Read more
Biotechnology NRX’s (NASDAQ: NRXP) NMDA Modification Therapy And Its Multiple Applications From Mental Health To Chronic Pain – NRX Pharmaceuticals (NASDAQ:NRXP) Read more
Biotechnology Analysts Express Confidence in Alnylam’s Hypertension Drug Despite Mixed Trial Data – Alnylam Pharmaceuticals (NASDAQ:ALNY) Read more
Biotechnology Supernus Pharmaceuticals Faces Second FDA Rejection For Investigational Device For Parkinson’s Disease Why Is Supernus Pharmaceuticals Stock Trading Lower on Monday> – Supernus Pharmaceuticals (NASDAQ:SUPN) Read more